23.09.2011 • News

Enzon Pharmaceuticals To Cut Nearly Half Of Its Workforce

 

Enzon Pharmaceuticals Thursday announced a 48% reduction in employees to more closely align its resources with the company's research and development activities.

Results for the ongoing quarter would include a charge related to the workforce reduction.

The reduction in force will reduce the number of employees by approximately 48%, to a total of 47, effective June 2012.

Enzon expects the reduction in force to result in approximately $6.0 million in reduced annualized operating expenses once the plan is fully implemented by the second quarter of 2012.

The Piscataway, New Jersey-headquartered company also expects to incur a charge in the third quarter of 2011 of approximately $3.0 million related to the reduction.

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

On Demand | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.